The use of androgen deprivation therapy in prostate cancer is now a well-established treatment regimen but is associated with an increased risk for bone fracture.
Paul R. Sieber, MD, FACS
Advertisement
Articles by Paul R. Sieber, MD, FACS
Advertisement
Latest Updated Articles
Maintaining Bone Health During ADT for Prostate CancerFebruary 20th 2018
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Breakthrough Therapy Designation to Olomorasib in KRAS G12C+ Pancreatic Cancer
2
Rethinking Lung Cancer Screening Paradigms
3
Dr Ferrarotto on the Investigation of Emi-Le in Aggressive Adenoid Cystic Carcinoma
4
Frontline Zanubrutinib Plus Obinutuzumab Elicits Complete Responses in Older Patients With MCL
5